3-cyano-7-ethoxycoumarin has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies
Studies (3-cyano-7-ethoxycoumarin) | Trials (3-cyano-7-ethoxycoumarin) | Recent Studies (post-2010) (3-cyano-7-ethoxycoumarin) | Studies ((3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid) | Trials ((3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid) | Recent Studies (post-2010) ((3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid) |
---|---|---|---|---|---|
6 | 0 | 3 | 1,459 | 368 | 396 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chou, KC; Li, L; Li, YX; Wang, JF; Wei, DQ; Zheng, SY | 1 |
1 other study(ies) available for 3-cyano-7-ethoxycoumarin and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design.
Topics: Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2C19; Drug Design; Fatty Acids, Monounsaturated; Fluvastatin; Fluvoxamine; Indoles; Ligands; Mixed Function Oxygenases; Models, Molecular; Nitriles; Protein Conformation; Structure-Activity Relationship; Ticlopidine | 2007 |